CONFERENCE REPORT

TRYPAN 2025

Global Virtual Symposium on Trypanosomiasis

September 24, 2025 Online
01
ABOUT THE EVENT

Global Virtual Symposium on Trypanosomiasis 2025

TRYPAN 2025 Global Virtual Symposium on Trypanosomiasis September 24, 2025 | Online Organized by: Impact Research Communications

The Global Virtual Symposium on Trypanosomiasis 2025 convened leading parasitologists, molecular biologists, clinicians, and public health specialists to discuss the latest advances in understanding Trypanosoma parasites. The one-day online event served as a dynamic platform to exchange knowledge on molecular mechanisms, diagnostics, drug targets, and new approaches to control African and American trypanosomiasis.

02
KEY MOMENTS

Highlights

Metabolism & Transmission

  • Frederic Bringaud (France) revealed how glycerol metabolism influences T. brucei transmission to flies.
  • Ariel Silber (Brazil) presented computational models of trypanosome energy metabolism.

Therapeutic Insights

  • Mark Field (UK) discussed benzoxaboroles and their trypanocidal mechanisms.
  • Santuzza Teixeira (Brazil) highlighted T. cruzi trans-sialidases as vaccine targets.

Gene Regulation & Diagnostics

  • Susanne Kramer (Germany) expanded understanding of mRNA export.
  • Joanna Faria (UK) explored RNA decay in antigen expression.
  • Lucy Glover (France) introduced a CRISPR-based diagnostic tool for African trypanosomiasis.

Pathogenesis & Control

  • Alex Cordoba-Aguilar (Mexico) shared field strategies to control infected kissing bugs.
  • Sergio Schenkman (Brazil) examined factors driving T. cruzi pathogenesis.
  • Michele Klingbeil (USA) expanded tools for mitochondrial DNA replication studies.
  • Abdulbasit Amin (Portugal) demonstrated how stimulating gluconeogenesis can promote host survival.
03
OUTCOMES

Impact

The symposium underscored the global urgency of trypanosomiasis research, bridging molecular biology with translational applications. By uniting experts from Europe, Latin America, Africa, and North America, the event advanced collaborative efforts toward new therapies, diagnostics, and vector control strategies.

04
GLOBAL REACH

Countries Participated

Argentina Brazil France Germany Japan Mexico Portugal Spain United Kingdom USA